Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Huang, Ming Hong"'
Autor:
Mei-ting Chen, Fei Pan, Yung-chang Chen, Wei Zhang, Hui-juan Lv, Zhao Wang, Huang-ming Hong, Xiao-jie Fang, Ya-wen Wang, Tao Pan, Li-qun Zou, Hong-qiang Guo, Ke Xie, Li-min Chen, Xiao-qian Li, Yu-yi Yao, Ze-geng Chen, Hua-wei Weng, Xu-dong Li, Yuan-yuan Shen, Hui Zhou, Hong-wei Xue, Hui-lai Zhang, He Huang, Tong-yu Lin
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Adult sporadic Burkitt lymphoma (BL) is a rare but highly aggressive subtype of lymphoma which lacks its own unique prognostic model. Systemic inflammatory biomarkers have been confirmed as prognostic markers in several types of m
Externí odkaz:
https://doaj.org/article/085eb186ea544bb4a14ce0b595e4d080
Autor:
He Huang, Li Min Chen, Xiao Jie Fang, Cheng Cheng Guo, Xiao Ping Lin, Huang Ming Hong, Xi Li, Zhao Wang, Ying Tian, Mei Ting Chen, Yu Yi Yao, Zegeng Chen, Xiao Qian Li, Fei Pan
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
BackgroundExtranodal natural killer/T-cell lymphoma (ENKTL) is a rare and extremely malignant tumor. The systemic inflammation score (SIS), which is based on the pretreatment level of lymphocyte-to-monocyte ratio (LMR) and serum albumin (Alb), has b
Externí odkaz:
https://doaj.org/article/9bdfb7f2f4774834971bd6a1fd7e6046
Autor:
Huang, Ming-Hong a, Lin, Wei-Chieh a, Fan, Chia-Chan a, Wang, Yu-Shih a, Lin, Hao-Wu a, ⁎, Liao, Jia-Ling b, Lin, Cheng-Huei b, Chi, Yun b, ⁎
Publikováno v:
In Organic Electronics May 2015 20:36-42
Autor:
Fan, Chia-Chan a, Huang, Ming-Hong a, Lin, Wei-Chieh a, Lin, Hao-Wu a, ⁎, Chi, Yun b, Meng, Hsin-Fei c, Chao, Teng-Chih d, Tseng, Mei-Rurng d
Publikováno v:
In Organic Electronics February 2014 15(2):517-523
Autor:
Qing Li, Hao Luo, Yuan-Yuan Luo, Wei Zhang, Huang-Ming Hong, Meng-Sheng Deng, Yang Wang, Bo Xu, Guan-Bin Song, Cheng-Xiong Xu
Publikováno v:
Chemical Engineering Journal. 437:135369
Autor:
Shu Liu, Chengcheng Guo, Tongyu Lin, Zhao Wang, Quanguang Ren, Fangfang Li, Huang Ming Hong, Chen Peng, Xiaojie Fang, Ying Tian, He Huang, Xueying Li
Publikováno v:
Journal of Clinical Oncology. 37:e13518-e13518
e13518 Background: The use of rituximab(RTX)for the treatment of primary central nervous system lymphoma(PCNSL) is controversial, and whether the RTX permeability of the blood-brain barrier can be improved by craniotomy is unknown. Methods: Immunocom
Autor:
Xiaojie Fang, Fangfang Li, Qing Liu, He Huang, Tongyu Lin, Limei Zhang, Xueying Li, Suxia Lin, Fushen Sha, Zhao Wang, Quanguang Ren, Huang Ming Hong, Chen Peng
Publikováno v:
Journal of Clinical Oncology. 36:7560-7560
7560Background: Patients with diffuse large B-cell lymphoma (DLBCL) with a high International Prognostic Index (IPI) are at higher risk for relapse after a complete response (CR) to first-line ritu...
Autor:
Zhao Wang, Mengping Zhang, Xiaoting Lin, Prem Raj Shrestha, Tongyu Lin, Xiaohong Fu, Huang Ming Hong, Ying Tian, Shanshan Li, Xiaojie Fang, He Huang, Xueying Li, Chengcheng Guo
Publikováno v:
Journal of Clinical Oncology. 33:e19508-e19508
e19508 Background: Ritubximab (RTX) with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) regimen is a gold standard therapy in treatment of diffuse large B-cell lymphoma (DLBCL)...
Autor:
Ying Tian, Chengcheng Guo, Xiaohong Fu, Mengping Zhang, Zhao Wang, Rm Bei, Xiaoting Lin, Shanshan Li, Tongyu Lin, Huang Ming Hong, Chaoyong Liang, Xiaojie Fang, He Huang, Xueying Li
Publikováno v:
Journal of Clinical Oncology. 32:8562-8562
8562 Background: Predictive tumor markers are essential for extranodal NK/T cell lymphoma, nasal type (ENKL), which pursues an aggressive clinical course with poorer prognosis. This prospective stu...